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Intrarectal infection between men who have sex with men represents a predominant form of
human immunodeficiency virus (HIV) transmission in developed countries. Currently there are
no adequate small animal models that recapitulate intrarectal HIV transmission. Here we
demonstrate that human lymphocytes generated in situ from hematopoietic stem cells reconstitute the gastrointestinal tract of humanized mice with human CD4+ T cells rendering them
susceptible to intrarectal HIV transmission. HIV infection after a single intrarectal inoculation
results in systemic infection with depletion of CD4+ T cells in gut-associated lymphoid tissue
and other pathologic sequela that closely mimics those observed in HIV infected humans. This
novel model provides the basis for the development and evaluation of novel approaches aimed
at immune reconstitution of human gut-associated lymphoid tissue and for the development,
testing, and implementation of microbicides to prevent intrarectal HIV-1 transmission.
CORRESPONDENCE
J. Victor Garcia:
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Intrarectal infection by HIV, the causative agent
of AIDS, is an important mode of HIV transmission currently accounting for over 400,000
cases in the United States. Presently, rhesus macaques (1) inoculated intrarectally with simian
immunodeficiency virus (SIV) or SIV/HIV chimeric viruses (SHIV) are the principal surrogate animal model to study intrarectal HIV
infection. There are no small animal models for
this mode of HIV transmission or to study infection in the gastrointestinal (GI) tract, which
in the early stages of HIV infection of humans,
is a major site of virus replication. Subsequent
depletion of CD4+ T cells in gut-associated
lymphoid tissue (GALT) is a defining event in
the course and outcome of disease (2, 3). With
the aim of elucidating the molecular determinants of HIV transmission via the rectum and
to establish a small animal model in which the
efficacy of early drug prophylaxis, microbicides,
and vaccines could be tested, we determined
the susceptibility of bone marrow/liver/thymus
(BLT) humanized mice (4) to intrarectal infection with HIV-1. In BLT mice, the bone marrow is reconstituted with human hematopoietic
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stem cells producing all human lymphoid lineages resulting in systemic repopulation. In addition, bone marrow–derived T cell progenitors
are produced that repopulate an implanted human organoid consisting of a piece of autologous fetal liver and thymus resulting in human
MHC-restricted functional T cells (4).
In this report, we demonstrate the in vivo
repopulation of the mouse GALT with human
hematopoietic cells derived from transplanted
human stem cells. Based on this observation,
we also provide the first demonstration of the
exquisite susceptibility of BLT mice to intrarectal infection by cell-free HIV-1 that results
in systemic infection including plasma viremia, systemic CD4+ T cell depletion, and the
production of HIV-specific human antibodies.
Intrarectal infection of BLT mice represents a
significant advance that will facilitate the implementation of microbicides and prophylactics to
prevent HIV transmission.
RESULTS AND DISCUSSION
Reconstitution of the BLT GALT
with human lymphocytes
NOD/SCID mice are devoid of endogenous B
and T cells, and therefore, the mouse component
705

Figure 1. Reconstitution of the GI tract of humanized BLT mice.
(A) Immunohistochemical analysis of the small intestine of a BLT mouse
for the presence of human hematopoietic cells. Histological analysis was
performed on fixed/paraffin-embedded tissue sections for human CD45
(pan lymphocyte marker), CD4 (T cells, monocytes, and macrophages),
CD68 (monocytes and macrophages), and fascin (dendritic cells) as previously described (4). Panels are small intestine lamina propria (effector
site), and inserts are follicular lymphoid aggregates (inductive site). Bars,
50 μm. Sections stained with isotype-matched control antibodies did not
show staining in these tissues (not depicted). In addition, staining for
human CD11c and HLA-DR of a BLT mouse together with staining of a
nonhumanized mouse with the same primary and secondary antibodies
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as an additional control are shown in Fig. S1. (B) Reconstitution of the
GI tract from humanized mice. The entire GI tract was harvested 24 wk
after transplant and separated into mesenteric LNs and large and small
intestine. IELs and LPLs were isolated from both large and small intestines.
Human hematopoietic cells were identified with anti–human CD45 antibodies and characterized for expression of lineage and differentiation
specific markers as indicated in the different panels. Human T cells in this
analysis were sequentially gated as CD45+®CD3+ or CD19+. CD45+CD3+
cells were analyzed for CD4+ or CD8+ expression (indicated with longer
arrow between first and second panels). CD4+ or CD8+ cells were further
analyzed for CD27 and CD45RA expression (indicated by the shorter
arrow between the second and third row of panels for CD4+ cells and a
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to mucosal immunity is limited to myeloid cells. To determine if human lymphoid cells encounter adequate signals to
migrate into and repopulate the mouse GI tract, we first harvested the small intestine of humanized BLT mice (n = 7)
and determined the presence of human hematopoieitic cells
24 wk after transplant. Histological analysis indicated an
abundant accumulation of CD45+ hematopoietic cells that
included human CD4+ cells, monocyte/macrophages, and
DCs (Fig. 1 A and Fig. S1, available at http://www.jem.org/
cgi/content/full/jem.20062411/DC1). We then characterized
the human hematopoietic cells in different parts of the GI
tract from humanized BLT mice by isolating lamina propria
lymphocytes (LPLs) and intraepithelial lymphocytes (IELs)
from large and small intestine. In all cases, the gating strategy
for flow cytometric analysis first identified human lymphoid
cells based on their expression of the human leukocyte common marker CD45 and then by the appropriate lineage
marker (i.e., CD3 or CD19) followed by the specific subset
(i.e., CD4 and/or CD8). All portions of the mouse GALT
were reconstituted with human hematopoietic cells, albeit
at different levels (Fig. 1 B). Human CD19+ B and CD3+
T cells were identified in all fractions with single positive
CD4 and CD8 human T cells representing the majority of
human lymphoid cells in all portions of the reconstituted
GALT. Substantial numbers of intraepithelial (IE) and lamina
propria (LP) CD4+CD8+ double positive human T cells
were found in the small intestine (Fig. 1 B). The CD8 molecule expressed on human double positive T cells present in
the LP was predominantly the CD8α chain (Fig. 1 C). In
contrast, the CD8 single positive cells in the LP expressed
both the CD8α and CD8β chains (Fig. 1 C). These observations are fully consistent with what has been described for
human gut (5, 6). Also consistent with what has been found
in human gut, DCs represent a small proportion of the
human lymphoid cells present, and lineage negative HLADRbright CD11c+ DC were most prominent in the small
intestine IEL and LPL fractions (Fig. S1) (7). Phenotypic
characterization of the T cells present in the different GALT
fractions indicated that the majority of both CD4+ and
CD8+ human T cells were CD27+CD45RA− memory cells.
Because the mesenteric LNs are the secondary lymphatic
tissues that drain the GI tract and play a major role in virus
dissemination after intrarectal HIV infection, we determined
that these important lymphoid tissues were also reconstituted
with human T and B cells. In contrast to LPL and IEL, mesenteric
LN contained a clear population of naive (CD45RA+CD27+)
T cells that were absent from the GALT.

Differential expression of CCR5 and CXCR4 in the BLT GALT
Coreceptor expression in human CD4+ cells is the major
determinant of HIV tropism in vivo (8). Analysis of both
CD4+ and CD8+ T cells present in the GALT of BLT mice
indicated differential expression of CXCR4 and CCR5. The
proportion of cells expressing CXCR4 and their respective
expression levels were generally low in all fractions of the
GALT except the mesenteric LN (Fig. 1 D for one representative BLT mouse and Fig. 1 E for the average [±SEM] for
seven BLT mice). In contrast, the levels of expression and the
proportion of cells expressing CCR5 were significantly higher
in all fractions of the GALT (Fig. 1, D and E). Analysis of
CCR5 expression on T cells in the gut with those from other
lymphoid and nonlymphoid tissues demonstrated that the
highest proportion of CD4+ CCR5+ cells were found in the
GALT (Fig. 1 E). These results are consistent with what has
been previously observed in human and macaque GALT
(9–11) and extend our understanding to other organs like the
liver and spleen. Collectively, these data establish the reconstitution of the GALT of humanized BLT mice with all of the human hematopoietic cells relevant to mucosal HIV transmission.
Furthermore, phenotypic analysis of GI tract and mesenteric
LN demonstrates that they are reconstituted in a manner that
closely resembles that of normal human and macaque tissues.

large arrow between the second and fourth row of panels for CD8+ cells).
In all cases individual gates were set using isotype-matched controls (not
depicted). (C) Small intestine IEL and LPL CD8+ and CD4+CD8+ cells were
further analyzed for their differential expression of CD8α and CD8β
chains using the same gating strategy as for B. D shows a comparison of
the levels of HIV coreceptor expression in human CD4+ and CD8+ T cells
isolated from the large and small intestine and the mesenteric LNs of BLT

mice. CD45+CD3+CD4+ or CD45+CD3+CD8+ cells from a representative
mouse were analyzed for expression of CXCR4 or CCR5. (E) Distribution of
CCR5 and CXCR4 coreceptor expression in human T cell subsets in gut,
lymphoid, and nonlymphoid tissues of humanized BLT mice. Shown are
averages of the indicated replicates with their respective error bars
(±SEM). Gating was performed in the same manner as indicated in D.
DP, double positive.
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Intrarectal infection of BLT mice with HIV-1
Because the anus, rectum, and colon are the most likely anatomical sites of initial infection after intrarectal exposure, we
determined that these regions of the BLT mouse intestinal
tract were repopulated with human CD4+ T cells (Fig. 2 A).
CD4+ cells were found in abundant clusters within the follicular aggregates and throughout the lamina propria of both
colon and rectum. Because we found that humanized BLT
mice had human CD4+ T cells throughout their GALT, we
were encouraged to determine the susceptibility of the BLT
mice to infection by HIV-1 administered intrarectally. Both
nonhumanized control (n = 4) and humanized BLT mice
(repopulated with human cells, n = 7) were inoculated intrarectally with a single dose of cell-free HIV-1 (LAI CXCR4
strain, 200 ng p24 in PBS) and subsequently monitored for
evidence of infection by assays for viral load and HIV antigenemia in the plasma. None of the HIV inoculated nonhumanized control mice showed any evidence of infection either
in the plasma or in the tissues upon necropsy (not depicted).
Similarly, none of the uninfected humanized BLT control mice
showed evidence of infection (n = 4). In contrast, viral RNA and
HIV antigenemia (capsid p24) were evident in the plasma of six
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Figure 2. Intrarectal HIV infection of humanized BLT mice.
(A) Immunohistochemical analysis of the colon and rectum of humanized
BLT mice for the presence of human lymphocytes expressing CD4. Histological analysis was performed on fixed/paraffin-embedded tissue sections
as previously described (4). Shown are two magnifications of each tissue
(top and bottom) where bars indicate 25 μm and 12.5 μm, respectively.
Sections stained with isotype-matched control antibodies did not
show staining in these tissues and no cross-reactivity was observed with
NOD/SCID mice tissue stained with anti–human CD4-specific antibodies
(not depicted and Fig. S1). (B) Peripheral blood from intrarectally infected
BLT (filled circles) or mock-infected control BLT mice (triangles) was analyzed for RNA viral load (copies per ml plasma, open symbols) and virus
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antigenemia (pg of p24 per ml plasma, filled symbols). (C) Western blot
analysis of plasma from infected mice for the presence of human IgG
antibodies specific for HIV proteins. Lane 1, plasma from a control mouse;
lanes 2–4, plasma samples from three HIV-infected mice; lane 5, plasma from
an HIV-infected individual. The position of the different HIV proteins in the
gel is indicated on the right. (D) Specific depletion of human CD4+ cells
from the peripheral blood of HIV-infected (squares) or control (triangles)
humanized BLT mice. (E) Human T cell flow cytometry profile of the
peripheral blood from a representative infected humanized BLT mouse
2 and 8 wk after intrarectal inoculation with cell-free HIV showing the
depletion of CD4+ human T cells.
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out of seven HIV-inoculated BLT mice (Fig. 2 B). Furthermore,
human IgG anti-HIV–specific antibodies were found in the
plasma of three out of four infected BLT mice tested (Fig. 2 C).
The appearance of viral RNA in the plasma of infected
BLT mice (Fig. 2 B) preceded or coincided with a decline
in peripheral blood human CD4+ T cells (Fig. 2 D). This
decline eventually resulted in an almost complete depletion of human CD4+ T cells from peripheral blood (Fig. 2,
D and E). Parallel to the decline of CD4+ T cells, there was
an increase in the percentage of human CD8+ T cells that
by 8 wk after inoculation represented the vast majority of
the human T cells in the periphery of infected humanized
BLT mice (Fig. 2 D). These results demonstrate the striking
susceptibility of BLT mice to infection by HIV administered intrarectally.

Peripheral blood serves as the most accessible site to monitor HIV replication, but the lymphatic tissues are the principal
sites of virus production, persistence, CD4+ T cell depletion,
and pathology. We therefore harvested the different internal
organs from infected mice 8 wk after inoculation and investigated the disseminated systemic infection of lymphatic tissues
after intrarectal challenge. We found productively infected
(HIV RNA+) cells in LNs, spleen, and human thymic tissue
(Fig. 3 A). In addition, we also documented the presence of
productively infected cells in lung, large and small intestine,
and the male and female reproductive tracts (Fig. 3 A). Consistent with what has been reported in humans and SIV-infected
rhesus macaques, we found that most productively infected
HIV RNA+ cells in humanized BLT mice were in fact human
T cells (Fig. 3 B). Furthermore, replication-competent HIV

Figure 3. Disseminated HIV infection of humanized BLT mice.
(A) In situ hybridization analysis of different tissues from infected humanized
BLT mice for the presence of cells productively infected with HIV. Autoradiograph images were obtained using brightfield microscopy. Boxes indicate areas shown at higher magnification on the right where bars indicate
25 μm and 12.5 μm, respectively. (B) In situ hybridization of HIV-infected

cells and immunocytochemical analysis for human CD3 expression in
spleen and lung of humanized BLT mice. Arrows indicate productively
infected CD3+ human T cells. Bars, 12.5 μm. Productive infection with
replication competent virus was confirmed by rescue of infectious virus
from spleen, human thymic tissue, and bone marrow of infected humanized BLT mice by coculture with activated human PBMCs (Fig. S2).
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was recovered from cells isolated from tissues obtained from
infected mice (Fig. S2, available at http://www.jem.org/cgi/
content /full/jem.20062411/DC1).These results highlight the
disseminated infection that results after intrarectal exposure
and the striking parallels between BLT mouse and human
HIV infection in the most relevant tissue compartments.
Systemic depletion of human CD4+ T cells
in HIV-1–infected BLT mice
We documented a dramatic depletion of human CD4+ T cells
in bone marrow, human thymic tissue, spleen, and LNs of
infected BLT mice (Fig. 4 A–C). In addition, there was
extensive depletion of human CD4+ T cells from lung and
liver (Fig. 4, A and C). Furthermore, compared with uninfected BLT mice, there was a dramatic reduction in the levels
of human CD4+ T cells in the large and small intestine and
in the mesenteric LN of HIV-infected mice (Fig. 4 B). Histological examination of the human thymic tissue and mouse
GI tract of infected animals revealed striking pathology (Fig.
4 D and Fig. S3, available at http://www.jem.org/cgi/content/
full/jem.20062411/DC1), most likely caused by loss of thymocytes and stromal collapse. The histological images show the
dramatic hypocellularity within the large and small intestine
that is consistent with our flow cytometry analysis showing
a dramatic loss of CD4+ T cells within this compartment
(Fig. 4 B) (3, 12).
Because depletion of CD4+ T cells from the GALT is a
major consequence of HIV infection, we characterized the
human lymphoid cells present in both small and large intestine after infection. Compared with uninfected BLT mice,
there was a dramatic reduction in the levels of human CD4+
T cells in the large and small intestine and in the mesenteric
LN of HIV-infected mice (Fig. 4 B). Decrease in CD4+
T cells coincided with reciprocal increases in the percentage of CD8+ T cells. Surprisingly, very few human CD8+ T
cells were found in the small intestine LPL and IEL fractions
of HIV-infected mice (Fig. 4, B and C). The proportion of
CD8+ T cells expressing CXCR4 in mesenteric LN and
large intestine significantly decreased, whereas the levels of
CD8+CCR5+ human T cells increased after HIV infection
compared with uninfected BLT mice (Fig. 5 A). Importantly,
the most dramatic change in coreceptor expression was noted
in the mesenteric LNs, which contained very high levels of
HIV-infected cells (Fig. 3 A) and where virtually all CD8+
human T cells expressed high levels of CCR5 (Fig. 5 A).
Consistent with what is seen in human infections (3), the
human T cells remaining in the BLT mouse GI tract after
infection (mostly CD8+; Fig. 4 B) had an effector memory
phenotype (CD27− CD45RA−) (Fig. 5 B) (13). Finally, we
characterized the frequency of CD8+ cells present in the
lymph node before and after HIV infection for further evidence of a general effector T cell response. Consistent with
their role as a major site of ongoing viral replication and a
principle immune inductive site, we demonstrated a dramatic
infiltration of human CD8+, granzyme+, and perforin+ cells
within the LNs of HIV-infected BLT mice (Fig. 5 C).
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Lymphocyte migration into effector tissues like the gut is the
result of a series of poorly understood but highly complex interactions between cell adhesion molecules, integrins, chemokines, and chemokine receptors. Our results demonstrate
the high degree of compatibility between the mouse and human systems that results in the appropriate repopulation of
the mouse gut tissue with human lymphoid cells. For the
most part, the reconstituted BLT gut clearly resembles human gut descriptions in the literature (5, 6). Perhaps the most
telling features were the presence of human CD4CD8αα
cells, a T cell subset known only to exist in GALT, and the
presence of abundant Peyer’s patches in the small intestine
and lymphoid follicular aggregates in the large intestine localized with human lymphocytes (T and B), macrophages, and
DCs. In addition, human lymphocytes (T and B), macrophages, and DCs were found distributed throughout the effector lamina propria in humanized BLT mice suggesting that
these mice have largely “normal human” GALT. However,
some differences were also noted. For example, there was
heterogeneity in the repopulation of human cells within the
lamina propria of each humanized BLT mice, with some
portions of the gut demonstrating lower repopulation. In addition, there were somewhat higher percentages of CD4+
T cells in BLT small intestine IELs compared with normal
human gut, and no γδT cells were identified. Despite these
differences and based on the remarkable similarities observed
between the GALT of BLT mice and humans, we tested the
susceptibility of humanized BLT mice to mucosal HIV transmission. A clear understanding of the molecular basis of mucosal HIV transmission has been hindered to a significant
extent by the lack of adequate systems that recapitulate the
events taking place during human infection. Our results show
remarkable similarities between intrarectally HIV-infected
humanized mice, HIV-infected humans, and SIV-infected
macaques including the devastating effects to the GALT.
One notable difference was a delay in peak viremia compared
with infected macaques. The 2-wk delay in peak of viremia is probably because of the chimeric nature of the model,
with a lower density of viral targets in humanized BLT mice
compared with macaques, which also could explain the relatively lower magnitude of viremia compared with infected
macaques. Therefore, from the context of HIV transmissibility, our observations represent a remarkable finding. The fact
that either very low levels of viral replication takes place in
regions of low target cell densities or the preservation of virus
infectivity until localized into tissues with suitable numbers of
target cells implies that this virus has incredible resilience that
has not been fully appreciated before.
Because of the limited species tropism of HIV, there are
few models where potential clinical interventions can be evaluated and where pathogenesis can be studied. Mice represent
an outstanding model to study a variety of aspects related to
numerous virus infections. However, mice are refractory to
HIV infection and cannot support HIV replication (14–16).
Thus, the susceptibility of humanized BLT mice to one intrarectal HIV exposure points to the great potential of this system
INTRARECTAL INFECTION OF HUMANIZED MICE WITH HIV | Sun et al.
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Figure 4. Depletion of human CD4+ T cells from the GALT of HIVinfected humanized BLT mice. (A) Flow cytometry analysis of human
T cells isolated from the indicated organs from a control and an HIVinfected humanized BLT mouse. Tissue samples were collected 8 wk after
inoculation, and mononuclear cells were obtained for flow cytometry
analysis as indicated in Materials and methods. The gating strategy was
human CD45+®CD3+ and then CD4 and CD8. (B) Depletion of human
CD4+ T cells from the small and large intestine and mesenteric LN of an
HIV-infected BLT mouse. (C) Comparison of the percentages of human

JEM VOL. 204, April 16, 2007

CD4+ T cells between control and HIV-infected BLT mice. Bars represent
averages of the indicated number of mice (±SEM). Asterisks in C serve to
indicate the virtual absence of human cells in the small intestine after HIV
infection. (D) Comparison of thymic and gut tissues of control and HIVinfected BLT mice showing the considerable damage inflicted by the viral
infection. Boxes indicate areas of the image shown at higher magnification
on the right where bars indicate 50 μm and 25 μm, respectively. Larger
images showing greater detail for thymic organoid and large intestine are
included in Fig. S3. DP, double positive.
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Figure 5. Phenotypic analysis of human CD8+ T cells before
and after HIV infection. (A) Coreceptor expression in human CD8+
T cells after HIV infection. Cells were isolated from gut tissue 8 wk after
infection and from a noninfected control BLT mouse. Cells were then
analyzed for CXCR4 and CCR5 expression. The gating strategy was
CD45+CD3+CD8+ and then CXCR4 or CCR5. (B) Analysis of CD27 and
CD45RA expression in human CD8+ T cells from an infected humanized
BLT mouse. The gating strategy was the same as in A but instead of
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coreceptor expression, CD27 and CD45RA expression were analyzed.
(C) Analysis of the effector T cell response to HIV in LNs. Shown are
images of lymph node tissue from a control (not infected) BLT mouse and
an HIV-infected BLT mouse stained for CD8, granzyme B, perforin, and
HIVp24. Note the dramatic infiltration by human CD8+ cells and the
increase in the numbers of cells expressing granzyme B and perforin
in the tissue from the infected animal. Bars, 25 μm.
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to study mucosal HIV transmission and prevention. In addition, the CD4+ T cell depletion and disease-defining pathology observed in our system demonstrate the utility of this
small animal model to address key questions regarding HIVinduced pathogenesis. Furthermore, the AIDS-like pathology
and depletion of the BLT GALT after HIV infection highlights its usefulness to evaluate therapeutic interventions aimed
at GALT reconstitution that might result in the possible reestablishment of a functional immune system in humans.
Therefore, the BLT humanized mouse model has great potential to evaluate novel approaches for the prevention and
treatment of HIV infection, from preclinical evaluation of
microbicides to preexposure prophylactic regimens aimed at
preventing the spread of AIDS.
MATERIALS AND METHODS
Preparation of humanized BLT mice and isolation of tissue
lymphocytes for flow cytometry analysis. Humanized mice were prepared essentially as we have previously described (4) and maintained under
specific pathogen-free conditions at the University of Texas Southwestern
Medical Center, at Dallas under protocols approved by the Animal Research
Committee. In brief, NOD/SCID-hu mice (17) were transplanted with autologous human fetal liver CD34+ cells 3 wk after implantation and monitored
for human reconstitution in peripheral blood by flow cytometry every 2–4 wk
starting 6 wk after transplant as we have previously described (4). Peripheral
blood analysis by flowcytometry was performed using anti–human CD45
pan-leukocyte antibodies to identify human hematopoietic cells. Using this
gate, all other human lineages and subsets were analyzed. Animals were anesthetized with sodium pentobarbital and then killed via cardiac puncture and
exsanguinations 24 wk after transplant. Tissues for immunohistochemical
analysis and for in situ hybridization analysis were fixed immediately upon
harvest and shipped to Dr. A.T. Haase in Minnesota for processing and analysis within 48 h of harvest. Immunohistochemical stainings and in situ hybridization analysis were performed essentially as previously described (4, 12, 18).
For controls, tissues were stained with isotype match nonspecific antibodies.
The specificity of each stain was also confirmed by staining tissue from
NOD/SCID control animals with the same antibodies to human antigens.
Tissue and blood samples were processed immediately for cell isolation and
flow cytometry analysis. The gating strategy for each subset of cells included
first human CD45 to identify human cells and to exclude mouse cells from
the analysis. Human cells were then analyzed for the specific human leukocyte antigens indicated in Figs. 1, 2, 4, 5, and S1. Flow cytometry data were
collected on the same day of harvest using a FACSCanto instrument with
Diva software. Isolation of cells from the gut took 5 h. In brief, single cell
suspensions for analysis were prepared essentially as we have previously described (4) except for GALT. GALT cells were prepared as previously described (19, 20) with modifications. Small and large intestine were flushed
with ice cold PBS, cut into 1-inch segments, and inverted to expose the
intraepithelial surface. These segments were washed five times by vigorous shaking in cold PBS, allowed to settle by gravity, then resuspended in
15–25 ml IEL extraction medium (freshly made; 3% FBS, 1 mM DTT, 1 mM
EDTA in PBS). These mixtures were shaken gently for 30 min on a rotating
platform at 37°C, then vigorously for 2 min at RT. The IEL supernatants
were collected through a 70-μm cell strainer (Falcon). The intestinal segments were thoroughly washed and incubated for 60 min on a rotating platform at 37°C in 15–25 ml LPL digestion medium (freshly made; 60 μg/ml
collagenase D and 10 U/ml DNaseI in RPMI-1640). During this incubation,
the IEL supernatants were passed over IEL extraction medium–equilibrated
columns of 0.5 g of dimethyldichlorosilane-treated glass wool fiber (Fisher) in
10-ml syringes. The column flow-through fractions were washed at 200 g for
5 min at 4°C, resuspended in solution B (0.5% BSA, 1 μg/ml penicillin G,
1 U/ml streptomycin, 1% citrate phosphate dextrose solution [CPD; Baxter],
25 mM KH2PO4, and 25 mM K2HPO4), and placed on ice. After the LPL
JEM VOL. 204, April 16, 2007

digestion, the suspensions were shaken mildly for 1 min at RT. The LPL supernatants were collected through a 70-μm cell strainer, washed at 200 g for
5 min at 4°C, resuspended in solution B, and placed on ice. Live cells from
both the IEL and LPL fractions of the small and large intestines were then
counted using trypan blue exclusion and used for flow cytometry analysis.
Intrarectal infection of humanized mice with HIV. Virus stocks were
prepared and titrated and p24 content was determined as we have previously
described (21, 22). Before inoculation, mice were anesthetized with sodium
nembutal. Intrarectal inoculations were performed essentially as previously
described using a total volume of 60–80 μL of virus (200 ng p24, 9 × 104
TCIU) (23).
Analysis of HIV infection of humanized mice. Infection of BLT mice
with HIV was monitored in peripheral blood every 2 wk by determining
viral load (Amplicore; Roche), levels of viral antigenemia (ELISA p24; Beckman
Coulter), and the levels of human CD4+ and CD8+ T cells in peripheral
blood (flow cytometry), and by determining the presence of human antibodies to HIV proteins in plasma essentially as we have previously described
(4, 21). Analysis of systemic infection was performed 8 wk after infection by
in situ hybridization, immunohistochemistry, and flow cytometry also as we
have previously described (4, 12). Rescue of infectious virus from different
tissues was performed by coculture with PHA-activated PBMC from HIV
seronegative donors, and viral spread was monitored by determining p24
levels in the culture supernatant. Human CD4+ T cell depletion was monitored in all tissues indicated essentially as we have previously described except that the six-color flow cytometry analysis also included determination
of CCR5 and CXCR4 expression (4).
Online supplemental material. Fig. S1 shows immunohistochemical
analysis for human CD11c and HLA-DR–positive cells in the gut of BLT
mice and flow cytometry analysis for the presence of human DC and NK
cells. In addition, it demonstrates the lack of cross-reactivity of the humanspecific antibodies used with mouse antigens. Fig. S2 demonstrates the rescue of replication-competent HIV from the spleen, thymic organoid, and
bone marrow of infected BLT mice. Fig. S3 presents high resolution images
showing the histopathological changes observed in the thymic organoid and
large intestine during HIV infection. Figs. S1–S3 available at http://www
.jem.org/cgi/ content /full/jem.20062411/DC1.
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